中国快讯 (ChinaCrunch) 为中国读者提供及时的加密新闻、市场洞察和监管动态。
China Approves Pfizer GLP-1 Drug for Long Term Weight Management
China has approved a new GLP 1 based drug developed by Pfizer for long term weight management in adults who are overweight or obese, marking another step in the rapid expansion of the country’s metabolic health treatment market. The approval allows the injectable